MediFind

Find a Doctor

Shoichi Maruyama

Nagoya University Graduate School Of Medicine
Male

Bio


Shoichi Maruyama is in Nagoya, Japan. They have been an author on 392 peer reviewed articles in the past 15 years. Dr. Maruyama's top three areas of expertise are Minimal Change Disease, Glomerulonephritis, and Membranous Nephropathy.

Contact

Nagoya, JP

Latest Research


Latest Advance
Study
  • Condition: Immunoglobulin A Nephropathy
  • Journal: JAMA network open
  • Treatment Used: Tonsillectomy
  • Number of Patients: 1065
  • Published —
The aim of the study was to investigate the possible association between tonsillectomy and outcomes in patients with IgA nephropathy.
Latest Advance
Study
  • Condition: Stage 3 Chronic Kidney Disease and Asymptomatic Hyperuricemia
  • Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Treatment Used: Febuxostat Therapy
  • Number of Patients: 467
  • Published —
The study aimed to determine the effects of febuxostat therapy (uric acid reducer) in treating stage 3 chronic kidney disease and asymptomatic hyperuricemia.
Latest Advance
Study
  • Condition: Adult-Onset Steroid-Dependent Nephrotic Syndrome (SDNS)
  • Journal: Clinical and experimental nephrology
  • Treatment Used: Rituximab
  • Number of Patients: 8
  • Published —
This study investigated patients with adult-onset steroid-dependent nephrotic syndrome (SDNS) who were treated with rituximab.
Latest Advance
Study
  • Condition: Adult Patients with Atypical Hemolytic-Uremic Syndrome (aHUS) in Japan
  • Journal: Clinical and experimental nephrology
  • Treatment Used: Eculizumab
  • Number of Patients: 60
  • Published —
This study assessed the safety and effectiveness of eculizumab in adult patients with atypical hemolytic-uremic syndrome (aHUS) in Japan.
Latest Advance
Study
  • Condition: Japanese Patients with Lupus Nephritis (LN)
  • Journal: Clinical and experimental nephrology
  • Treatment Used: Mycophenolate Mofetil (MMF) and Therapeutic Drug Monitoring (TDM)
  • Number of Patients: 20
  • Published —
This study investigated the benefits of mycophenolate mofetil (MMF) and therapeutic drug monitoring (TDM) in the treatment of Japanese patients with lupus nephritis (LN).
Latest Advance
Study
  • Condition: Hyperuricaemia/diabetic nephropathy
  • Journal: Nephrology (Carlton, Vic.)
  • Treatment Used: Topiroxostat
  • Number of Patients: 80
  • Published —
This study evaluated the effects of topiroxostat in hyperuricaemic patients with diabetic nephropathy.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Nagoya, JP

Insurance

Contact them to find out if they accept your insurance plan.